FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Report

The world's most expensive drugs

Genzyme drugs take four spots among the most expensive in a Forbes survey (chart). The developer's rare disease treatments Myozyme, Fabrazyme, Cerezyme and Aldurazyme all cost over $200,000 per year. But the Cerezyme price is likely to head south following last week's FDA approval of Shire's Gaucher treatment, velaglucerase alfa for injection. Alexion Pharmaceuticals takes the top spot for the world's most expensive drug, Soliris. The therapy costs $409,500 per year. Report

Special Report

Top 12 GMP Violations

Sometimes it's process complexity, a lack of training, or carelessly done paperwork that leads FDA inspectors to cite drug companies for violating current good manufacturing practices. But at other times violations appear to be attempts to pull the wool over inspectors' eyes. Here's a list of the top 12 GMP violations from the last year. Report